Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02860104 | Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions | unknown | Phase 2 / Phase 3 | 500 | Chinese PLA General HospitalOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02958033 | Shandong Cancer Hospital Affiliated to Shandong University | unknown | Phase 3 | 100 | Shandong Cancer Hospital and InstituteOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02830685 |
| Pre-pectoral Breast Reconstruction PART 1(PreBRec) |
| unknown |
| Phase 3 |
| 131 |
| Guy's and St Thomas' NHS Foundation TrustOTHER |
| 1 |
| Oct 3, 2016 |
| clinicaltrials |
| NCT02831426 | Pre-pectoral Breast Reconstruction PART 2(PreBRec) | unknown | Phase 3 | 86 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT02865304 | The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | unknown | Phase 3 | 80 | Fujian Cancer HospitalOTHER_GOV | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02802826 | Studying Tailored Exercise Prescriptions in Breast Cancer Patients(STEPS) | unknown | Phase 3 | 100 | Loughborough UniversityOTHER | 1 | Jun 16, 2016 | clinicaltrials |
| NCT02383030 | Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients(FUMANCE) | unknown | Phase 3 | 156 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02394496 | Overcoming Endocrine Resistance in Metastatic Breast Cancer(OVER) | unknown | Phase 3 | 396 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02404051 | Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer(FEVEX) | unknown | Phase 3 | 745 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | unknown | Phase 3 | 529 | NSABP Foundation IncNETWORK | 3 | Jun 6, 2016 | clinicaltrials |
| NCT02690636 | Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer | unknown | Phase 3 | 500 | Ain Shams UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02097459 | Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer | unknown | Phase 3 | 600 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT00402519 | APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer | unknown | Phase 3 | 1,300 | University of Erlangen-Nürnberg Medical SchoolOTHER | 5 | May 13, 2016 | clinicaltrials |
| NCT02207335 | Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer | unknown | Phase 3 | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT02595138 | Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer | unknown | Phase 3 | 430 | Chinese Academy of Medical SciencesOTHER | 0 | Nov 3, 2015 | clinicaltrials |
| NCT02336529 | Nerveblocks for Persistent Pain After Breast Cancer Surgery | unknown | Phase 3 | 48 | Kenneth Geving AndersenOTHER | 0 | Oct 27, 2015 | clinicaltrials |
| NCT01509781 | Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study | unknown | Phase 3 | 400 | National Institute of Oncology, HungaryOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01204801 | Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors(Medifocus301) | unknown | Phase 3 | 238 | Medifocus, Inc.INDUSTRY | 2 | Sep 24, 2015 | clinicaltrials |
| NCT02468882 | Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial | unknown | Phase 3 | 200 | University of LisbonOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT02449954 | Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses | unknown | Phase 2 / Phase 3 | 60 | Assiut UniversityOTHER | 0 | May 21, 2015 | clinicaltrials |
| NCT02292407 | Prospective Pilot Study ANDPrecise(ANDPrecise) | unknown | Phase 3 | 20 | The Netherlands Cancer InstituteOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT02249208 | Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.(SENTINAC-01) | unknown | Phase 3 | 150 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT01402193 | Study of Arimidex and Radiotherapy Sequencing | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT02132390 | Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea | unknown | Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT02141139 | Perioperative Inflammation and Breast Cancer Outcome | unknown | Phase 3 | 1,568 | Samsung Medical CenterOTHER | 1 | May 19, 2014 | clinicaltrials |
| NCT02035631 | Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention(PREDICOP) | unknown | Phase 3 | 2,000 | Institut Català d'OncologiaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00003418 | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer | unknown | Phase 3 | 4,400 | International Collaborative Cancer GroupOTHER | 3 | Dec 19, 2013 | clinicaltrials |
| NCT00003678 | Tamoxifen in Treating Women With Breast Cancer | unknown | Phase 3 | 20,000 | University Hospital BirminghamOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 3 | 1,000 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00010140 | Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 3 | — | International Collaborative Cancer GroupOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00859989 | A Weight-Loss Program in Helping Obese Black Women Lose Weight | unknown | Phase 3 | 200 | University of Illinois at ChicagoOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT00003679 | Combination Chemotherapy in Treating Women With Breast Cancer | unknown | Phase 3 | 350 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | unknown | Phase 3 | 300 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01622361 | Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer(NEST) | unknown | Phase 3 | 290 | Asan Medical CenterOTHER | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00688194 | Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy | unknown | Phase 3 | 396 | Gruppo Italiano Mammella (GIM)OTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01089764 | Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer(couplelinks) | unknown | Phase 3 | 260 | Canadian Breast Cancer Research AllianceOTHER | 1 | Aug 14, 2013 | clinicaltrials |
| NCT00966888 | Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy | unknown | Phase 3 | 3,500 | Medical Research CouncilOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00002455 | Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma | unknown | Phase 3 | — | Centro Oncologico de ExcelenciaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00002460 | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer | unknown | Phase 3 | — | Cancer Research UKOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT00006030 | Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer | unknown | Phase 3 | — | British Association of Surgical Oncology: Breast GroupOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00039546 | Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery | unknown | Phase 3 | — | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00070278 | Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer | unknown | Phase 3 | 800 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00516425 | Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer | unknown | Phase 3 | 1,000 | Charing Cross HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | unknown | Phase 3 | 2,500 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01917578 | Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction(BCSMANC) | unknown | Phase 3 | 4 | Shandong Cancer Hospital and InstituteOTHER | 1 | Aug 6, 2013 | clinicaltrials |
| NCT00072020 | Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 3 | — | University of SheffieldOTHER | 0 | Aug 2, 2013 | clinicaltrials |
| NCT00559858 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer | unknown | Phase 3 | 270 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00963209 | Tamoxifen Citrate in Patients With Breast Cancer | unknown | Phase 3 | 140 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | unknown | Phase 3 | 800 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 0 | Aug 2, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 23, 2016source: clinicaltrials